表紙
市場調查報告書

全球臉部脂肪移植市場:2025年為止的預測

Global Facial Fat Transfer Market Research Report - Forecast till 2025

出版商 Market Research Future 商品編碼 926864
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
全球臉部脂肪移植市場:2025年為止的預測 Global Facial Fat Transfer Market Research Report - Forecast till 2025
出版日期: 2019年12月01日內容資訊: 英文 145 Pages
簡介

全球臉部脂肪移植市場成長,由於身體美學的重要性高漲,流行和電影產業的影響造成的社會及文化要素所帶動。但,先進技術和美容手術相關的嚴格法規政策的認識缺乏,妨礙該市場的成長。

本報告提供全球臉部脂肪移植市場的相關調查,市場機會,成長及阻礙因素,各目標區域、治療、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場概要
  • 市場魅力分析
  • 各目標區域
  • 各治療
  • 各終端用戶

第2章 市場概要

  • 定義
  • 調查範圍
  • 調查目的
  • 市場結構
  • 前提條件與限制

第3章 調查方法

  • 資料探勘
  • 二次調查
  • 一次調查
  • 主要的受訪者的明細
  • 預測技術
  • 市場規模估計的調查方法
    • Bottom-Up(由下而上)方法
    • Top-Down(由上而下)方法
  • 資料的三角形分割
  • 檢驗

第4章 市場動態

  • 概要
  • 成長要素
    • 身體美學的重要性的高漲
    • 流行和電影產業的影響造成的社會及文化要素
  • 阻礙因素
    • 嚴格的法規政策
    • 使用先進技術的認識不足
  • 市場機會
    • 開發經濟的進入
    • 對微創手術的需求上升

第5章 市場要素分析

  • 波特的五力分析
  • 價值鏈分析
    • 研究開發與設計
    • 製造業
    • 分佈
    • 行銷銷售
    • 銷售後的監視

第6章 市場分析:目標各區域

  • 概要
  • 法令紋
  • 嘴唇
  • 木偶紋
  • 太陽穴
  • 下巴
  • 眼下的區域

第7章 市場分析:各治療

  • 概要
  • 皮膚填充劑
  • 脂肪注射

第8章 市場分析:各終端用戶

  • 概要
  • 醫院
  • 美容外科診所
  • 其他

第9章 市場分析:各地區

  • 概要
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
  • 東歐
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區
  • 中東、非洲
    • 中東
    • 非洲

第10章 競爭情形

  • 概要
  • 企業佔有率分析
  • 競爭基準
  • 開發數量的市場主要企業
  • 主要的開發分析
    • 產品的銷售
    • 核准
    • 合併、收購
    • 擴張
    • 聯盟、契約

第11章 企業簡介

  • ALLERGAN
  • DR. KORMAN
  • GALDERMA LABORATORIES, L.P.
  • INTEGRA LIFESCIENCES CORPORATION
  • MERZ PHARMA
  • SCIVISION BIOTECH INC.
  • SINCLAIR PHARMA
  • SUNEVA MEDICAL
  • BAUSCH HEALTH COMPANIES INC.
  • TEOXANE LABORATORIES
  • IPSEN PHARMA

第12章 附錄

  • 參考文獻
  • 相關報告
目錄

Title:
Global Facial Fat Transfer Market:
Information by Target Area, Treatment, End User and Region - Forecast till 2025.

Market Analysis

Facial fat transfer is a minimally invasive surgical procedure to move fat from an area of the body where it is plentiful and transfer it to the face to restore lost volume. The fat is gently removed using modern liposuction techniques and is then prepared for injecting into the face. Several dermal fillers are available in the market, designed to improve different parts of the face. The factors leading to the growth of the global facial fat transfer market are rising importance of body aesthetics and social and cultural factors such as influence of fashion and film industries are driving the market growth. However, lack of awareness for the use of advanced technologies and stringent regulatory policies related to aesthetic procedures hampers the market growth.

Market segmentation

The facial fat transfer market, based on target area, continues to be segmented into Naso-labial folds, lips, marionette folds, temples, chin, under-eye area. The facial fat transfer markets, based on treatment, have been segmented into the dermal fillers, fat injection and others. Based on end user, the market is segmented into hospitals, cosmetic surgery clinics and others. By end user the hospitals segment accounted for the largest market share of 49.20% in 2018, with a market value of USD 1,845.74 million and expects to reach USD 4,064.70 million by 2025 at a CAGR of 12%.

Regional analysis

Based on region the global facial fat transfer market is divided up into the Americas, Europe, Asia-Pacific, and also the Middle East and Africa. The increasing awareness regarding body aesthetics and the introduction of advanced technology in the facial rejuvenation industry are major factors that drive the growth of the global facial fat transfer market. The Americas is anticipated to be the largest market share due to the presence of major players and increasing demand for the beauty treatment in the region. North America accounted for the larger market share of 82.10% in 2018 and expected to grow at a healthy CAGR during the forecasted period. Europe accounts for the second-largest market share in the global facial fat transfer market. The increasing demand for minimally invasive cosmetic procedures and reimbursement policies drives the market growth in Europe region. Asia-Pacific is anticipated to be the fastest growing market forecast period. The investing in research and development of facial fat transfer methods and growing number of hospitals performing this procedures drives the market growth. which will ultimately boost the growth of the market. Moreover, the Middle Eastern and Africa is likely to exhibit the lowest growth owing to the limited access and availability of treatment facilities. Moreover, limited developments in technology may slow market growth.

Major players

The industrial development, product improvement, and strategic collaboration are few crucial techniques followed by the global players operating in the facial fat transfer market. The major key players in the global facial fat transfer market are Allergan (Ireland), Teoxane Laboratories (Switzerland), DR. Korman (Israel), Integra LifeSciences Corporation (Israel), Merz Pharma (Germany), SciVision Biotech Inc. (Taiwan), Sinclair Pharma (UK), Suneva Medical, Inc. (US), Bausch Health Companies Inc. (Canada), Galderma Laboratories, L.P. (US), Ipsen Pharma (France) as well as others.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 MARKET SYNOPSIS 16
  • 1.2 MARKET ATTRACTIVENESS ANALYSIS 17
  • 1.3 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA 18
  • 1.4 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT 19
  • 1.5 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER 20

2 MARKET INTRODUCTION

  • 2.1 DEFINITION 21
  • 2.2 SCOPE OF THE STUDY 21
  • 2.3 RESEARCH OBJECTIVE 21
  • 2.4 MARKET STRUCTURE 21
  • 2.5 ASSUMPTIONS & LIMITATIONS 22

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING 23
  • 3.2 SECONDARY RESEARCH 24
  • 3.3 PRIMARY RESEARCH 25
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 26
  • 3.5 FORECASTING TECHNIQUES 27
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 28
    • 3.6.1 BOTTOM-UP APPROACH 29
    • 3.6.2 TOP-DOWN APPROACH 29
  • 3.7 DATA TRIANGULATION 30
  • 3.8 VALIDATION 30

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 31
  • 4.2 DRIVERS 32
    • 4.2.1 RISING IMPORTANCE OF BODY AESTHETICS 32
    • 4.2.2 SOCIAL AND CULTURAL FACTORS SUCH AS INFLUENCE OF FASHION AND FILM INDUSTRIES 32
  • 4.3 RESTRAINTS 33
    • 4.3.1 STRINGENT REGULATORY POLICIES 33
    • 4.3.2 LACK OF AWARENESS FOR THE USE OF ADVANCED TECHNOLOGIES 33
  • 4.4 OPPORTUNITIES 34
    • 4.4.1 ENTERING DEVELOPING ECONOMIES 34
    • 4.4.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 34

5 MARKET FACTOR ANALYSIS 35

  • 5.1 PORTER'S FIVE FORCES MODEL 35
    • 5.1.1 BARGAINING POWER OF SUPPLIERS 35
    • 5.1.2 BARGAINING POWER OF BUYERS 36
    • 5.1.3 THREAT OF NEW ENTRANTS 36
    • 5.1.4 THREAT OF SUBSTITUTES 36
    • 5.1.5 INTENSITY OF RIVALRY 36
  • 5.2 VALUE CHAIN ANALYSIS 37
    • 5.2.1 R&D AND DESIGNING 38
    • 5.2.2 MANUFACTURING 38
    • 5.2.3 DISTRIBUTION 38
    • 5.2.4 MARKETING & SALES 38
    • 5.2.5 POST-SALES MONITORING 38

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL 35
    • 5.1.1 BARGAINING POWER OF SUPPLIERS 35
    • 5.1.2 BARGAINING POWER OF BUYERS 36
    • 5.1.3 THREAT OF NEW ENTRANTS 36
    • 5.1.4 THREAT OF SUBSTITUTES 36
    • 5.1.5 INTENSITY OF RIVALRY 36
  • 5.2 VALUE CHAIN ANALYSIS 37
    • 5.2.1 R&D AND DESIGNING 38
    • 5.2.2 MANUFACTURING 38
    • 5.2.3 DISTRIBUTION 38
    • 5.2.4 MARKETING & SALES 38
    • 5.2.5 POST-SALES MONITORING 38

6 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA

  • 6.1 OVERVIEW 39
  • 6.2 NASO-LABIAL FOLDS 40
  • 6.3 LIPS 41
  • 6.4 MARIONETTE FOLDS 41
  • 6.5 TEMPLES 42
  • 6.6 CHIN 43
  • 6.7 UNDER-EYE AREA 43

7 GLOBAL FACIAL FAT TRANSFER MARKET, TREATMENT

  • 7.1 OVERVIEW 45
  • 7.2 DERMAL FILLERS 46
  • 7.3 FAT INJECTION 48

8 GLOBAL FACIAL FAT TRANSFER MARKET, END USER

  • 8.1 OVERVIEW 49
  • 8.2 HOSPITALS 50
  • 8.3 COSMETIC SURGERY CLINICS 51
  • 8.4 OTHERS 51

9 GLOBAL FACIAL FAT TRANSFER MARKET, BY REGION

  • 9.1 OVERVIEW 52
  • 9.2 AMERICAS 53
    • 9.2.1 NORTH AMERICA 56
    • 9.2.2 LATIN AMERICA 63
  • 9.3 EUROPE 65
    • 9.3.1 WESTERN EUROPE 68
  • 9.4 EASTERN EUROPE 83
  • 9.5 ASIA-PACIFIC 85
    • 9.5.1 JAPAN 88
    • 9.5.2 CHINA 90
    • 9.5.3 INDIA 92
    • 9.5.4 SOUTH KOREA 94
    • 9.5.5 AUSTRALIA 96
    • 9.5.6 REST OF ASIA-PACIFIC 98
  • 9.6 MIDDLE EAST & AFRICA 100
    • 9.6.1 MIDDLE EAST 103
    • 9.6.2 AFRICA 105

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW 107
  • 10.2 COMPANY SHARE ANALYSIS 107
  • 10.3 COMPETITIVE BENCHMARKING 108
  • 10.4 LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN FACIAL FAT TRANSFER MARKET 109
  • 10.5 KEY DEVELOPMENT ANALYSIS 109
    • 10.5.1 PRODUCT LAUNCH 110
    • 10.5.2 APPROVAL 110
    • 10.5.3 MERGER & ACQUISITION 111
    • 10.5.4 EXPANSION 112
    • 10.5.5 PARTNERSHIPS AND AGREEMENTS 113

11 COMPANY PROFILE

  • 11.1 ALLERGAN 114
    • 11.1.1 COMPANY OVERVIEW 114
    • 11.1.2 FINANCIAL OVERVIEW 115
    • 11.1.3 PRODUCTS/SERVICES OFFERED 115
    • 11.1.4 KEY DEVELOPMENTS 116
    • 11.1.5 SWOT ANALYSIS 117
    • 11.1.6 KEY STRATEGIES 117
  • 11.2 DR. KORMAN 118
    • 11.2.1 COMPANY OVERVIEW 118
    • 11.2.2 FINANCIAL OVERVIEW 118
    • 11.2.3 PRODUCTS/SERVICES OFFERED 118
    • 11.2.4 KEY DEVELOPMENTS 118
    • 11.2.5 SWOT ANALYSIS 119
    • 11.2.6 KEY STRATEGIES 119
  • 11.3 GALDERMA LABORATORIES, L.P. 120
    • 11.3.1 COMPANY OVERVIEW 120
    • 11.3.2 FINANCIAL OVERVIEW 120
    • 11.3.3 PRODUCTS/SERVICES OFFERED 121
    • 11.3.4 KEY DEVELOPMENTS 121
    • 11.3.5 SWOT ANALYSIS 122
    • 11.3.6 KEY STRATEGIES 122
  • 11.4 INTEGRA LIFESCIENCES CORPORATION 123
    • 11.4.1 COMPANY OVERVIEW 123
    • 11.4.2 FINANCIAL OVERVIEW 123
    • 11.4.3 PRODUCTS/SERVICES OFFERED 124
    • 11.4.4 KEY DEVELOPMENTS 124
    • 11.4.5 SWOT ANALYSIS 125
    • 11.4.6 KEY STRATEGIES 125
  • 11.5 MERZ PHARMA 126
    • 11.5.1 COMPANY OVERVIEW 126
    • 11.5.2 FINANCIAL OVERVIEW 126
    • 11.5.3 PRODUCTS/SERVICES OFFERED 127
    • 11.5.4 KEY DEVELOPMENTS 127
    • 11.5.5 SWOT ANALYSIS 128
    • 11.5.6 KEY STRATEGIES 128
  • 11.6 SCIVISION BIOTECH INC. 129
    • 11.6.1 COMPANY OVERVIEW 129
    • 11.6.2 FINANCIAL OVERVIEW 129
    • 11.6.3 PRODUCTS/SERVICES OFFERED 129
    • 11.6.4 KEY DEVELOPMENTS 129
    • 11.6.5 SWOT ANALYSIS 130
    • 11.6.6 KEY STRATEGIES 130
  • 11.7 SINCLAIR PHARMA 131
    • 11.7.1 COMPANY OVERVIEW 131
    • 11.7.2 FINANCIAL OVERVIEW 131
    • 11.7.3 PRODUCTS/SERVICES OFFERED 132
    • 11.7.4 KEY DEVELOPMENTS 132
    • 11.7.5 SWOT ANALYSIS 133
    • 11.7.6 KEY STRATEGIES 133
  • 11.8 SUNEVA MEDICAL 134
    • 11.8.1 COMPANY OVERVIEW 134
    • 11.8.2 FINANCIAL OVERVIEW 134
    • 11.8.3 PRODUCTS/SERVICES OFFERED 134
    • 11.8.4 KEY DEVELOPMENTS 134
    • 11.8.5 SWOT ANALYSIS 135
    • 11.8.6 KEY STRATEGIES 135
  • 11.9 BAUSCH HEALTH COMPANIES INC. 136
    • 11.9.1 COMPANY OVERVIEW 136
    • 11.9.2 FINANCIAL OVERVIEW 136
    • 11.9.3 PRODUCTS/SERVICES OFFERED 137
    • 11.9.4 KEY DEVELOPMENTS 137
    • 11.9.5 SWOT ANALYSIS 138
    • 11.9.6 KEY STRATEGIES 138
  • 11.10 TEOXANE LABORATORIES 139
    • 11.10.1 COMPANY OVERVIEW 139
    • 11.10.2 FINANCIAL OVERVIEW 139
    • 11.10.3 PRODUCTS/SERVICES OFFERED 139
    • 11.10.4 KEY DEVELOPMENTS 139
    • 11.10.5 SWOT ANALYSIS 140
    • 11.10.6 KEY STRATEGIES 140
  • 11.11 IPSEN PHARMA 141
    • 11.11.1 COMPANY OVERVIEW 141
    • 11.11.2 FINANCIAL OVERVIEW 141
    • 11.11.3 PRODUCTS/SERVICES OFFERED 142
    • 11.11.4 KEY DEVELOPMENTS 142
    • 11.11.5 SWOT ANALYSIS 143
    • 11.11.6 KEY STRATEGIES 143

12 APPENDIX

  • 12.1 REFERENCES 144
  • 12.2 RELATED REPORTS 144

List of Tables

  • TABLE 1 LIST OF ASSUMPTIONS 22
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 25
  • TABLE 3 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 40
  • TABLE 4 GLOBAL FACIAL FAT TRANSFER MARKET FOR NASO-LABIAL FOLDS, BY REGION, 2016-2025 (USD MILLION) 40
  • TABLE 5 GLOBAL FACIAL FAT TRANSFER MARKET FOR LIPS, BY REGION, 2016-2025 (USD MILLION) 41
  • TABLE 6 GLOBAL FACIAL FAT TRANSFER MARKET FOR MARIONETTE FOLDS, BY REGION, 2016-2025 (USD MILLION) 42
  • TABLE 7 GLOBAL FACIAL FAT TRANSFER MARKET FOR TEMPLES, BY REGION, 2016-2025 (USD MILLION) 42
  • TABLE 8 GLOBAL FACIAL FAT TRANSFER MARKET FOR CHIN, BY REGION, 2016-2025 (USD MILLION) 43
  • TABLE 9 GLOBAL FACIAL FAT TRANSFER MARKET FOR UNDER-EYE AREA, BY REGION, 2016-2025 (USD MILLION) 43
  • TABLE 10 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT, 2016-2025 (USD MILLION) 46
  • TABLE 11 GLOBAL FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY REGION, 2016-2025 (USD MILLION) 47
  • TABLE 12 GLOBAL FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 47
  • TABLE 13 GLOBAL FACIAL FAT TRANSFER MARKET FOR FAT INJECTION, BY REGION, 2016-2025 (USD MILLION) 48
  • TABLE 14 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER, 2016-2025 (USD MILLION) 50
  • TABLE 15 GLOBAL FACIAL FAT TRANSFER MARKET FOR HOSPITALS, BY REGION, 2016-2025 (USD MILLION) 50
  • TABLE 16 GLOBAL FACIAL FAT TRANSFER MARKET FOR COSMETIC SURGERY CLINICS, BY REGION, 2016-2025 (USD MILLION) 51
  • TABLE 17 AMERICAS: FACIAL FAT TRANSFER MARKET, BY REGION, 2016-2025 (USD MILLION) 53
  • TABLE 18 AMERICAS: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 54
  • TABLE 19 AMERICAS: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 54
  • TABLE 20 AMERICAS: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 55
  • TABLE 21 AMERICAS: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 55
  • TABLE 22 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 56
  • TABLE 23 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 57
  • TABLE 24 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 57
  • TABLE 25 NORTH AMERICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 58
  • TABLE 26 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 58
  • TABLE 27 US: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 59
  • TABLE 28 US: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 59
  • TABLE 29 US: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 60
  • TABLE 30 US: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 60
  • TABLE 31 CANADA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 61
  • TABLE 32 CANADA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 61
  • TABLE 33 CANADA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 62
  • TABLE 34 CANADA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 62
  • TABLE 35 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 63
  • TABLE 36 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 63
  • TABLE 37 LATIN AMERICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 64
  • TABLE 38 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 64
  • TABLE 39 EUROPE: FACIAL FAT TRANSFER MARKET, BY REGION, 2016-2025 (USD MILLION) 65
  • TABLE 40 EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 66
  • TABLE 41 EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 66
  • TABLE 42 EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 67
  • TABLE 43 EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 67
  • TABLE 44 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 68
  • TABLE 45 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 69
  • TABLE 46 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 69
  • TABLE 47 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 70
  • TABLE 48 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 70
  • TABLE 49 ITALY: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 71
  • TABLE 50 ITALY: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 71
  • TABLE 51 ITALY: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 72
  • TABLE 52 ITALY: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 72
  • TABLE 53 FRANCE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 73
  • TABLE 54 FRANCE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 73
  • TABLE 55 FRANCE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 74
  • TABLE 56 FRANCE: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 74
  • TABLE 57 GERMANY: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 75
  • TABLE 58 GERMANY: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 75
  • TABLE 59 GERMANY: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 76
  • TABLE 60 GERMANY: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 76
  • TABLE 61 UK: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 77
  • TABLE 62 UK: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 77
  • TABLE 63 UK: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 78
  • TABLE 64 UK: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 78
  • TABLE 65 SPAIN: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 79
  • TABLE 66 SPAIN: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 79
  • TABLE 67 SPAIN: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 80
  • TABLE 68 SPAIN: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 80
  • TABLE 69 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 81
  • TABLE 70 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 81
  • TABLE 71 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 82
  • TABLE 72 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 82
  • TABLE 73 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 83
  • TABLE 74 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 83
  • TABLE 75 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 84
  • TABLE 76 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 84
  • TABLE 77 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 85
  • TABLE 78 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 86
  • TABLE 79 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 86
  • TABLE 80 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 87
  • TABLE 81 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 87
  • TABLE 82 JAPAN: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 88
  • TABLE 83 JAPAN: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 88
  • TABLE 84 JAPAN: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 89
  • TABLE 85 JAPAN: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 89
  • TABLE 86 CHINA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 90
  • TABLE 87 CHINA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 90
  • TABLE 88 CHINA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 91
  • TABLE 89 CHINA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 91
  • TABLE 90 INDIA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 92
  • TABLE 91 INDIA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 92
  • TABLE 92 INDIA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 93
  • TABLE 93 INDIA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 93
  • TABLE 94 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 94
  • TABLE 95 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 94
  • TABLE 96 SOUTH KOREA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 95
  • TABLE 97 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 95
  • TABLE 98 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 96
  • TABLE 99 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 96
  • TABLE 100 AUSTRALIA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 97
  • TABLE 101 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 97
  • TABLE 102 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 98
  • TABLE 103 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 98
  • TABLE 104 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 99
  • TABLE 105 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 99
  • TABLE 106 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY REGION, 2016-2025 (USD MILLION) 100
  • TABLE 107 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 101
  • TABLE 108 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 101
  • TABLE 109 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 102
  • TABLE 110 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 102
  • TABLE 111 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 103
  • TABLE 112 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 103
  • TABLE 113 MIDDLE EAST: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 104
  • TABLE 114 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 104
  • TABLE 115 AFRICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016-2025 (USD MILLION) 105
  • TABLE 116 AFRICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016-2025 (USD MILLION) 105
  • TABLE 117 AFRICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016-2025 (USD MILLION) 106
  • TABLE 118 AFRICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016-2025 (USD MILLION) 106
  • TABLE 119 GLOBAL FACIAL FAT TRANSFER MARKET: COMPANY SHARE ANALYSIS, 2018 (%) 107
  • TABLE 120 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE FACIAL FAT TRANSFER MARKET 109
  • TABLE 121 PRODUCT LAUNCH 110
  • TABLE 122 APPROVAL 110
  • TABLE 123 MERGER & ACQUISITION 111
  • TABLE 124 EXPANSION 112
  • TABLE 125 PARTNERSHIPS AND AGREEMENTS 113
  • TABLE 126 ALLERGAN: PRODUCTS/SERVICES OFFERED 115
  • TABLE 127 ALLERGAN: KEY DEVELOPMENTS 116
  • TABLE 128 DR. KORMAN: PRODUCTS/SERVICES OFFERED 118
  • TABLE 129 GALDERMA: PRODUCTS/SERVICES OFFERED 121
  • TABLE 130 GALDERMA: KEY DEVELOPMENTS 121
  • TABLE 131 INTEGRA: PRODUCTS/SERVICES OFFERED 124
  • TABLE 132 INTEGRA: KEY DEVELOPMENTS 124
  • TABLE 133 MERZ PHARMA: PRODUCTS/SERVICES OFFERED 127
  • TABLE 134 MERZ PHARMA: KEY DEVELOPMENTS 127
  • TABLE 135 SCIVISION BIOTECH INC.: PRODUCTS/SERVICES OFFERED 129
  • TABLE 136 SINCLAIR PHARMA: PRODUCTS/SERVICES OFFERED 132
  • TABLE 137 SINCLAIR PHARMA: KEY DEVELOPMENTS 132
  • TABLE 138 SUNEVA MEDICAL: PRODUCTS/SERVICES OFFERED 134
  • TABLE 139 SUNEVA MEDICAL: KEY DEVELOPMENTS 134
  • TABLE 140 BAUSCH: PRODUCTS/SERVICES OFFERED 137
  • TABLE 141 TEOXANE: PRODUCTS/SERVICES OFFERED 139
  • TABLE 142 IPSEN PHARMA: PRODUCTS/SERVICES OFFERED 142
  • TABLE 143 IPSEN PHARMA: KEY DEVELOPMENTS 142

List of Figures

  • FIGURE 1 MARKET SYNOPSIS 16
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2018) 17
  • FIGURE 3 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY TARGET AREA 18
  • FIGURE 4 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY TREATMENT 19
  • FIGURE 5 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY END USER 20
  • FIGURE 6 GLOBAL FACIAL FAT TRANSFER MARKET: STRUCTURE 21
  • FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES 28
  • FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FACIAL FAT TRANSFER MARKET 31
  • FIGURE 9 DRIVER IMPACT ANALYSIS 32
  • FIGURE 10 RESTRAINT IMPACT ANALYSIS 33
  • FIGURE 11 PORTER'S FIVE FORCES ANALYSIS: GLOBAL FACIAL FAT TRANSFER MARKET 35
  • FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL FACIAL FAT TRANSFER MARKET 37
  • FIGURE 13 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY TARGET AREA, 2018 (%) 39
  • FIGURE 14 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2018 AND 2025 (USD MILLION) 39
  • FIGURE 15 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY TREATMENT, 2018 (%) 45
  • FIGURE 16 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT, 2018 AND 2025 (USD MILLION) 45
  • FIGURE 17 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY END USER, 2018 (%) 49
  • FIGURE 18 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER, 2018 AND 2025 (USD MILLION) 49
  • FIGURE 19 GLOBAL: FACIAL FAT TRANSFER MARKET, BY REGION 2016 & 2025 (USD MILLION) 52
  • FIGURE 20 GLOBAL: FACIAL FAT TRANSFER MARKET SHARE, BY REGION 2018 (%) 52
  • FIGURE 21 AMERICAS: FACIAL FAT TRANSFER MARKET SHARE, BY REGION 2018 (%) 53
  • FIGURE 22 NORTH AMERICA: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY 2018 (%) 56
  • FIGURE 23 EUROPE: PERFUSION RADIOLOGY MARKET SHARE, BY REGION 2018 (%) 65
  • FIGURE 24 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY 2018 (%) 68
  • FIGURE 25 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY2018 (%) 85
  • FIGURE 26 MIDDLE EAST & AFRICA: PERFUSION RADIOLOGY MARKET SHARE, BY REGION, 2018 (%) 100
  • FIGURE 27 BENCHMARKING OF MAJOR COMPETITORS 108
  • FIGURE 28 GLOBAL FACIAL FAT TRANSFER MARKET, COMPETITIVE LANDSCAPE 109
  • FIGURE 29 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT 115
  • FIGURE 30 ALLERGAN: SWOT ANALYSIS 117
  • FIGURE 31 DR. KORMAN: SWOT ANALYSIS 119
  • FIGURE 32 GALDERMA: FINANCIAL OVERVIEW SNAPSHOT 120
  • FIGURE 33 GALDERMA: SWOT ANALYSIS 122
  • FIGURE 34 INTEGRA: FINANCIAL OVERVIEW SNAPSHOT 123
  • FIGURE 35 INTEGRA: SWOT ANALYSIS 125
  • FIGURE 36 MERZ PHARMA: FINANCIAL OVERVIEW SNAPSHOT 126
  • FIGURE 37 MERZ PHARMA: SWOT ANALYSIS 128
  • FIGURE 38 SCIVISION BIOTECH INC.: SWOT ANALYSIS 130
  • FIGURE 39 SINCLAIR PHARMA: FINANCIAL OVERVIEW SNAPSHOT 131
  • FIGURE 40 SINCLAIR PHARMA: SWOT ANALYSIS 133
  • FIGURE 41 SUNEVA MEDICAL: SWOT ANALYSIS 135
  • FIGURE 42 BAUSCH: FINANCIAL OVERVIEW SNAPSHOT 136
  • FIGURE 43 BAUSCH: SWOT ANALYSIS 138
  • FIGURE 44 TEOXANE: SWOT ANALYSIS 140
  • FIGURE 45 IPSEN PHARMA: FINANCIAL OVERVIEW SNAPSHOT 141
  • FIGURE 46 IPSEN PHARMA: SWOT ANALYSIS 143